Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 79
  • 0 comments

FDA approve BIVALIRUDIN

Comment Full text

IDENTIRX

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 66
  • 0 comments

FDA approve DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

Comment Full text

MSN

  • FDA Approval
  • Feb. 20, 2025, 05:53 UTC
  • 81
  • 0 comments

FDA approve SUNITINIB MALATE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Feb. 20, 2025, 05:53 UTC
  • 78
  • 0 comments

FDA approve AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 63
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ABBVIE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 64
  • 0 comments

FDA approve AVIBACTAM SODIUM; AZTREONAM

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 74
  • 0 comments

FDA approve NAPROXEN

Comment Full text

DECIPHERA PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 78
  • 0 comments

FDA approve VIMSELTINIB

Comment Full text

IMPAX

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 70
  • 0 comments

FDA approve APIXABAN

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 71
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text
  • Previous
  • 236
  • 237
  • 238
  • 239
  • 240
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351097)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192850)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin